VIVIMEDLAB (21)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE implements Short-Term Additional Surveillance Measure (ST-ASM) on select securities with increased margin requirements effective January … | |||||||||||||||
NSE implements Short-Term Additional Surveillance Measure (ST-ASM) on select securities with increased margin requirements effective January 16, 2026.
| |||||||||||||||
BSE revises price bands for 14 scrips including ABM Knowledgeware, AI Champdany Industries, and others, effective January 7, 2026. | |||||||||||||||
BSE revises price bands for 14 scrips including ABM Knowledgeware, AI Champdany Industries, and others, effective January 7, 2026.
| |||||||||||||||
BSE announces revised price bands for 14 securities ranging from 2% to 10%, effective from January 7, 2026, as part of surveillance … | |||||||||||||||
BSE announces revised price bands for 14 securities ranging from 2% to 10%, effective from January 7, 2026, as part of surveillance measures.
| |||||||||||||||
BSE updates the list of securities subject to Short Term Additional Surveillance Measure framework, including new inclusions, movements … | |||||||||||||||
BSE updates the list of securities subject to Short Term Additional Surveillance Measure framework, including new inclusions, movements between stages, and exclusions effective January 06, 2026.
| |||||||||||||||
BSE announces securities being added to and removed from the Short Term ASM Framework effective January 06, 2026, with 8 securities newly … | |||||||||||||||
BSE announces securities being added to and removed from the Short Term ASM Framework effective January 06, 2026, with 8 securities newly shortlisted and 8 securities moving out.
| |||||||||||||||
NSE imposes Short-Term Additional Surveillance Measure (ST-ASM) Stage I on 4 securities with increased margin requirements effective January … | |||||||||||||||
NSE imposes Short-Term Additional Surveillance Measure (ST-ASM) Stage I on 4 securities with increased margin requirements effective January 7, 2026, and excludes 2 securities from ASM framework.
| |||||||||||||||
BSE revises price bands for 20 securities effective January 02, 2026, with bands ranging from 2% to 20%. | |||||||||||||||
BSE revises price bands for 20 securities effective January 02, 2026, with bands ranging from 2% to 20%.
| |||||||||||||||
Vivimed Labs Ltd. equity shares will be moved from their current group to 'B' group effective December 26, 2025. | |||||||||||||||
Vivimed Labs Ltd. equity shares will be moved from their current group to 'B' group effective December 26, 2025.
| |||||||||||||||
Vivimed Labs Limited (VIVIMEDLAB) will be transferred from BE series to EQ series effective December 26, 2025. | |||||||||||||||
Vivimed Labs Limited (VIVIMEDLAB) will be transferred from BE series to EQ series effective December 26, 2025.
| |||||||||||||||
BSE announces the revocation of suspension in trading of equity shares of Vivimed Labs Limited (Scrip Code: 532660). | |||||||||||||||
BSE announces the revocation of suspension in trading of equity shares of Vivimed Labs Limited (Scrip Code: 532660).
| |||||||||||||||